1. Academic Validation
  2. Efficient synthesis of indole-chalcones based glycohybrids and their anticancer activity

Efficient synthesis of indole-chalcones based glycohybrids and their anticancer activity

  • Bioorg Med Chem. 2024 Jul 15:109:117778. doi: 10.1016/j.bmc.2024.117778.
Rajdeep Tyagi 1 Kanchan Yadav 1 Ashish Khanna 2 Sunil K Mishra 3 Ram Sagar 4
Affiliations

Affiliations

  • 1 Glycochemistry Laboratory, School of Physical Sciences, Jawaharlal Nehru University, New Delhi 110067, India.
  • 2 Department of Chemistry, Institute of Science, Banaras Hindu University, Varanasi 221005, India.
  • 3 Department of Pharmaceutical Engineering and Technology, Indian Institute of Technology (IIT-BHU), Varanasi 221005, India.
  • 4 Glycochemistry Laboratory, School of Physical Sciences, Jawaharlal Nehru University, New Delhi 110067, India; Department of Chemistry, Institute of Science, Banaras Hindu University, Varanasi 221005, India. Electronic address: ram.sagar@jnu.ac.in.
Abstract

Indole based glycosides belong to the class of pharmacologically active molecules and found in diverse natural compounds. Herein, we report the synthesis of 1,2,3-triazole bridged chirally enriched diverse indole-chalcones based glycohybrids. Three series of glycohybrids were designed and efficiently synthesized using d-glucose, d-galactose and d-mannose derived 1-azido glycosides. The reactions sequence involved were, the synthesis of indole derived Chalcones which were formed via Claisen-Schmidt condensation reaction and subsequently N-propargylation which leads to the production of N-propargylated indole-chalcones. The N-propargylated indole-chalcones get transformed into 1,2,3-triazole bridged indole-chalcone based glycohybrids by reacting with 1-azido sugar glycosides under click-chemistry reaction conditions. Further, the biological activity of synthesized glycohybrids (n = 27) was assessed in-vitro against MDA-MB231, MCF-7, MDA-MB453 Cancer, and MCF-10A normal cell lines. The selected compounds showed potent anti-oncogenic properties against MCF-7 and MDA-MB231 breast Cancer cell line with IC50 values of 1.05 µM and 11.40 µM respectively, with very good selectivity index (SI > 161). The active compounds show better binding affinity as compared to co-crystallized inhibitor 1-(tert-butyl)-3-(p-tolyl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine (PP1) with HCK (PTKs) proteins in molecular docking studies.

Keywords

1,2,3-Triazole; Anti-Cancer activity; Click-Chemistry; Glycohybrids; Indole-chalcones; Molecular Docking.

Figures
Products